CRISPR-Cas9 genetic screen leads to the discovery of L-Moses, a KAT2B inhibitor that attenuates Tunicamycin-mediated neuronal cell death
CRISPR-Cas9 基因筛选导致发现 L-Moses,一种可减轻衣霉素介导的神经元细胞死亡的 KAT2B 抑制剂
期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-023-31141-6
Sofia Pavlou, Stefanie Foskolou, Nikolaos Patikas, Sarah F Field, Evangelia K Papachristou, Clive D' Santos, Abigail R Edwards, Kamal Kishore, Rizwan Ansari, Sandeep S Rajan, Hugo J R Fernandes, Emmanouil Metzakopian